Kadmon Holdings Inc 's ROA from the third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Kadmon Holdings Inc 's ROA in the third quarter of 2021?
Kadmon Holdings Inc recorded a cumulative net loss of $-121 million during 12 months ending in the third quarter of 2021, resulting in a negative return on assets (ROA) of -39.08%.

However, within the Healthcare sector 657 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2021 quarter, so far to 4311, from total ROA ranking in the second quarter of 2021 at 4351.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Total Assets Change	62.98 %	47.09 %	86.71 %	33.41 %	21.56 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-121	-111	-108	-109	-93
Return On Assets (TTM)	-39.08 %	-39.76 %	-42.38 %	-50.44 %	-46.86 %
KDMN's Total Ranking	# 4311	# 4351	# 4267	# 4846	# 4114
Total Assets (TTM) in million	304	310	335	287	187
Seq. Total Assets Change	-1.94 %	-7.41 %	16.94 %	53.5 %	-11.5 %
Seq. Net Income Change	-	-	-	-	-

KDMN's 5 Years Annual ROA >> Back to KDMN Management Effectiveness >> Compare KDMN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 299
Sector	# 658
Overall	# 4194

Return On Assets Statistics
High	Average	Low
-17.08 %	-91.51 %	-311.44 %
(Mar 31 2019)		(Dec 31 2016)

Financial Statements
Kadmon Holdings Inc 's Assets	$ 304 million	KDMN's Balance sheet
Kadmon Holdings Inc 's Income	$ -34 million	Quarterly KDMN's Income Statement
KDMN's Income by Division		See KDMN's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2014) FY 2016
Y / Y Total Assets Change	-24.25 %	94.24 %	32.36 %	-75.91 %	-
Total Assets in million	163	215	111	84	347
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-109	-61	-54	-80	-65
Annual Return On Assets	-66.94 %	-28.57 %	-49.06 %	-95.48 %	-18.73 %

KDMN's 5 Years Annual ROA >> Back to KDMN Management Effectiveness >> Compare KDMN ROA to its Competitors

More Return On Assets Ratios
KDMN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KDMN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KDMN's Competitors
Subscribers only: Roa for Kadmon Holdings Inc 's Suppliers
Subscribers only: Return On Assets for KDMN's Customers

You may also want to know
KDMN's Roi	KDMN's Inventory Turnover Ratio	KDMN's Growth Rates	KDMN's Dividend Comparisons
	KDMN's Profitability Ratios	KDMN's Asset Turnover Ratio	KDMN's Dividend Growth
KDMN's Roe	KDMN's Valuation Ratios	KDMN's Financial Strength Ratios	KDMN's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2021, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.